title: Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study.
abstract: OBJECTIVE
  To determine the extent of gender-related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences.
  
  
  METHODS
  Cross-sectional data were collected from a national cohort of 11 247 Australians aged > or = 25 years. Glucose tolerance status was assessed according to both fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) levels following a 75-g oral glucose tolerance test (OGTT). Anthropometric and glycated haemoglobin measurements were also made.
  
  
  RESULTS
  Undiagnosed diabetes and non-diabetic glucose abnormalities were more prevalent among men than women when based only on the FPG results (diabetes: men 2.2%, women 1.6%, P = 0.02; impaired fasting glycaemia: men 12.3%, women 6.6%, P < 0.001). In contrast 16.0% of women and 13.0% of men had a 2hPG abnormality (either diabetes or impaired glucose tolerance, P = 0.14). Women had a mean FPG 0.3 mmol/l lower than men (P < 0.001), but 2hPG 0.3 mmol/l higher (P = 0.002) and FPG-2hPG increment 0.5 mmol/l greater (P < 0.001). The gender difference in mean 2hPG and FPG-2hPG increment disappeared following adjustment for height. For both genders, those in the shortest height quartile had 2hPG levels 0.5 mmol/l higher than the tallest quartile, but height showed almost no relationship with the FPG.
  
  
  CONCLUSIONS
  Men and women had different glycaemic profiles; women had higher mean 2hPG levels, despite lower fasting levels. It appeared that the higher 2hPG levels for women related to lesser height and may be a consequence of using a fixed glucose load in the OGTT, irrespective of body size.
authors.affiliation: International Diabetes Institute, Melbourne, Victoria, Australia. rsicree@idi.org.au
authors.forename: R A
authors.initials: RA
authors.lastname: Sicree
authors.forename: P Z
authors.initials: PZ
authors.lastname: Zimmet
authors.forename: D W
authors.initials: DW
authors.lastname: Dunstan
authors.forename: A J
authors.initials: AJ
authors.lastname: Cameron
authors.forename: T A
authors.initials: TA
authors.lastname: Welborn
authors.forename: J E
authors.initials: JE
authors.lastname: Shaw
mesh_terms: D000328:Adult; D001315:Australia / Q000453:epidemiology; D001786:Blood Glucose / Q000378:metabolism*; D001827:Body Height; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000378:metabolism*; D004812:Epidemiologic Methods; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D008297:Male; D008875:Middle Aged; D012727:Sex Characteristics
chemical_list: D001786:Blood Glucose